Sheffield Medical Technologies Inc. deal

SHEF expanded its agreement with CBR Laboratories Inc. to include the production of SHEF's red blood cell (RBC)-CD4 Complex for use in upcoming Phase II trials in patients with HIV infection and AIDS. The complex is intended to absorb free-floating HIV and HIV-infected cells in the bloodstream. ...